Biological control of cucumber green mottle mosaic virus
An attenuated strain of cucumber green mottle mosaic virus (CGMMV) is useful to protect cucumber plants from infection with the wild-type infectious CGMMV strain. The genome of the attenuated virus contains at least one mutation or group of mutations selected from c.4969G>A, c.3334C>T, and a group of at least six of the mutations c.315G>A; c.1498A>G; c.1660C>T; c.3430C>T; c.3528A>G; c.4144C>T; c.4248C>T; and c.6228C>T. These mutated genomes encode one or more mutations selected from R163711 in the 186 kDa readthrough replication protein, A1092V in the 129 kDa replication protein and/or the 186 kDa readthrough replication protein, and at least six mutations selected from G86S, E480G, S534F, A1124V, N1157D, P1362L, P1397S in the 129 kDa replication protein and/or the 186 kDa readthrough replication protein, and the A156V mutation in the coat protein.
1. A polydeoxyribonucleotide having a sequence functionally equivalent to a sequence of a genome of an attenuated strain of cucumber green mottle mosaic virus (CGMMV), wherein the sequence of the polydeoxyribonucleotide is a variant of SEQ ID NO:18 comprising at least one of the following options a), b) and c):
a) A at the position corresponding to position 4969 of SEQ ID NO:18;
b) T at the position corresponding to position 3334 of SEQ ID NO:18; and
c) at least six nucleic acid bases selected from:
A at the position corresponding to position 315 of SEQ ID NO:18;
G at the position corresponding to position 1498 of SEQ ID NO:18;
T at the position corresponding to position 1660 of SEQ ID NO:18;
T at the position corresponding to position 3430 of SEQ ID NO:18;
G at the position corresponding to position 3528 of SEQ ID NO:18;
T at the position corresponding to position 4144 of SEQ ID NO:18;
T at the position corresponding to position 4248 of SEQ ID NO:18; and
T at the position corresponding to position 6228 of SEQ ID NO:18.
2. The polydeoxyribonucleotide according to claim 1 , wherein the sequence of the polydeoxyribonucleotide comprises one or more of A at the position corresponding to position 4969 of SEQ ID NO:18 and T at the position corresponding to position 3334 of SEQ ID NO:18.
3. The polydeoxyribonucleotide according to claim 1 , wherein the sequence of the polydeoxyribonucleotide comprises:
A at the position corresponding to position 315 of SEQ ID NO:18;
G at the position corresponding to position 1498 of SEQ ID NO:18;
T at the position corresponding to position 1660 of SEQ ID NO:18;
T at the position corresponding to position 3430 of SEQ ID NO:18;
G at the position corresponding to position 3528 of SEQ ID NO:18;
T at the position corresponding to position 4144 of SEQ ID NO:18;
T at the position corresponding to position 4248 of SEQ ID NO:18; and
T at the position corresponding to position 6228 of SEQ ID NO:18.
4. The polydeoxyribonucleotide according to claim 3 , wherein the sequence of the polydeoxyribonucleotide comprises one or more of A at the position corresponding to position 4969 of SEQ ID NO:18 and Tat the position corresponding to position 3334 of SEQ ID NO:18.
5. The polydeoxyribonucleotide according to claim 1 , wherein the sequence of the polydeoxyribonucleotide is selected from SEQ ID NO:42, SEQ ID NO:45, SEQ ID NO:48, SEQ ID NO:53, SEQ ID NO:58, SEQ ID NO:60, and variants thereof.
6. The polydeoxyribonucleotide according to claim 1 , wherein the sequence of the polydeoxyribonucleotide is selected from SEQ ID NO:42, SEQ ID NO:45, SEQ ID NO:48, SEQ ID NO:60, and variants thereof.
7. The polydeoxyribonucleotide according to claim 1 , wherein the polydeoxyribonucleotide encodes one or more proteins selected from:
a 129 kDa protein having an amino acid sequence selected from SEQ ID NO:43, SEQ ID NO:46, SEQ ID NO:49, SEQ ID NO:54, SEQ ID NO:61 and variants thereof;
a 186 kDa protein having an amino acid sequence selected from SEQ ID NO:44, SEQ ID NO:47, SEQ ID NO:50, SEQ ID NO:55, SEQ ID NO:59, SEQ ID NO:62 and variants thereof; and
a coat protein having an amino acid sequence selected from SEQ ID NO:32 and variants thereof.
8. A vector comprising the polydeoxyribonucleotide according to claim 1 .
9. A genetically modified cell, wherein the cell expresses the polydeoxyribonucleotide according to claim 1 .
10. The genetically modified cell according to claim 9 , wherein the cell is a microorganism.
11. The genetically modified cell according to claim 9 , wherein the cell is a plant cell.
12. A composition for preventing symptoms associated with infection by wild-type CGMMV in a plant or for increasing resistance of a plant to infection by wild-type CGMMV, wherein the composition comprises a genetically modified cell according to claim 9 and an agriculturally acceptable carrier.
13. A method for preventing symptoms associated with infection by wild-type CGMMV in a plant or for increasing resistance of a plant to infection by wild-type CGMMV, wherein the method comprises inoculating the plant with a genetically modified cell according to claim 9 .
14. A method for preventing symptoms associated with infection by wild-type CGMMV in a plant or for increasing resistance of a plant to infection by wild-type CGMMV, wherein the method comprises inoculating the plant with a composition according to claim 12 .